Membranous Nephropathy With Crescents: A Series of 19 Cases

医学 膜性肾病 系列(地层学) 肾小球肾炎 皮肤病科 肾病 病理 内科学 肾 内分泌学 糖尿病 古生物学 生物
作者
Erika F. Rodriguez,Samih H. Nasr,Christopher Patrick Larsen,Sanjeev M. Sethi,Mary E. Fidler,Lynn D. Cornell
出处
期刊:American Journal of Kidney Diseases [Elsevier BV]
卷期号:64 (1): 66-73 被引量:42
标识
DOI:10.1053/j.ajkd.2014.02.018
摘要

Background Membranous nephropathy (MN) with crescents is rare and, in the absence of lupus, usually is associated with anti–glomerular basement membrane (anti-GBM) nephritis or antineutrophil cytoplasmic antibody (ANCA)-positive glomerulonephritis. Only rare cases of crescentic MN without ANCA or anti-GBM have been reported. Study Design Case series. Setting & Participants 19 patients with ANCA- and anti-GBM−negative crescentic MN and no clinical evidence of systemic lupus. Outcomes Clinical features, kidney biopsy findings, laboratory results, treatment, and follow-up of patients with crescentic MN. Results Mean age was 55 (range, 5-86) years. All patients presented with proteinuria (mean protein excretion, 11.5 [range, 3.3-29] g/d) and nearly all had hematuria; 16 of 19 (84%) patients had decreased estimated glomerular filtration rates (eGFRs; mean serum creatinine, 2.9 [range, 0.4-10] mg/dL; mean eGFR, 39.7 [range, 4 to >100] mL/min/1.73 m2). Glomeruli showed on average 25% (range, 2%-73%) involvement by crescents. All showed a membranous pattern; 7 showed mesangial and 2 showed segmental endocapillary proliferation. By immunofluorescence, all cases showed granular subepithelial immunoglobulin G (IgG) and κ and λ light chains, and all but one showed C3; 5 showed C1q or IgA. Electron microscopy revealed stages I-III MN; 38% of cases were M-type phospholipase A2 receptor (PLA2R) associated, indicating that at least some were primary MN. Follow-up clinical data were available for all patients (mean, 22 [range, 1.5-138] months). 14 patients received immunosuppressive therapy, and 2, only angiotensin-converting enzyme inhibitor/angiotensin receptor blocker therapy. 4 patients (21%) progressed to end-stage renal disease, at 0-9 months postbiopsy. Mean serum creatinine level of those without end-stage renal disease at follow-up was 1.7 (range, 0.5-4.1) mg/dL; mean eGFR was 53.3 (range, 16-103) mL/min/1.73 m2. 67% of patients had proteinuria with protein excretion ≥ 1 (mean, 3.2) g/d at follow-up. Limitations Retrospective study. Conclusions Crescentic MN is a rare variant of MN that usually presents with heavy proteinuria, hematuria, and decline in GFR. The prognosis is variable and the disease may respond to therapy, but most patients develop a long-term decline in GFR. Membranous nephropathy (MN) with crescents is rare and, in the absence of lupus, usually is associated with anti–glomerular basement membrane (anti-GBM) nephritis or antineutrophil cytoplasmic antibody (ANCA)-positive glomerulonephritis. Only rare cases of crescentic MN without ANCA or anti-GBM have been reported. Case series. 19 patients with ANCA- and anti-GBM−negative crescentic MN and no clinical evidence of systemic lupus. Clinical features, kidney biopsy findings, laboratory results, treatment, and follow-up of patients with crescentic MN. Mean age was 55 (range, 5-86) years. All patients presented with proteinuria (mean protein excretion, 11.5 [range, 3.3-29] g/d) and nearly all had hematuria; 16 of 19 (84%) patients had decreased estimated glomerular filtration rates (eGFRs; mean serum creatinine, 2.9 [range, 0.4-10] mg/dL; mean eGFR, 39.7 [range, 4 to >100] mL/min/1.73 m2). Glomeruli showed on average 25% (range, 2%-73%) involvement by crescents. All showed a membranous pattern; 7 showed mesangial and 2 showed segmental endocapillary proliferation. By immunofluorescence, all cases showed granular subepithelial immunoglobulin G (IgG) and κ and λ light chains, and all but one showed C3; 5 showed C1q or IgA. Electron microscopy revealed stages I-III MN; 38% of cases were M-type phospholipase A2 receptor (PLA2R) associated, indicating that at least some were primary MN. Follow-up clinical data were available for all patients (mean, 22 [range, 1.5-138] months). 14 patients received immunosuppressive therapy, and 2, only angiotensin-converting enzyme inhibitor/angiotensin receptor blocker therapy. 4 patients (21%) progressed to end-stage renal disease, at 0-9 months postbiopsy. Mean serum creatinine level of those without end-stage renal disease at follow-up was 1.7 (range, 0.5-4.1) mg/dL; mean eGFR was 53.3 (range, 16-103) mL/min/1.73 m2. 67% of patients had proteinuria with protein excretion ≥ 1 (mean, 3.2) g/d at follow-up. Retrospective study. Crescentic MN is a rare variant of MN that usually presents with heavy proteinuria, hematuria, and decline in GFR. The prognosis is variable and the disease may respond to therapy, but most patients develop a long-term decline in GFR.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
DW的应助被小马采纳,获得10
2秒前
闲云野鹤完成签到,获得积分10
2秒前
彬彬完成签到,获得积分10
3秒前
谦让钥匙发布了新的文献求助10
3秒前
吗喽发布了新的文献求助10
3秒前
沉睡千年的蛆完成签到,获得积分10
4秒前
典雅秋白完成签到,获得积分10
4秒前
zyy发布了新的文献求助30
4秒前
温骐华完成签到 ,获得积分10
5秒前
缥缈月光完成签到,获得积分10
6秒前
共享精神的应助被敖烈采纳,获得10
6秒前
moose完成签到 ,获得积分10
6秒前
欢喜的乐安完成签到,获得积分10
6秒前
HaoruMeng发布了新的文献求助20
6秒前
7秒前
8秒前
寂寞的飞珍完成签到,获得积分10
8秒前
玛卡巴卡发布了新的文献求助10
9秒前
10秒前
乐乐的应助被Yanzhang0000采纳,获得10
10秒前
吗喽完成签到,获得积分10
11秒前
ZZ发布了新的文献求助10
11秒前
顾矜的应助被qqq采纳,获得10
11秒前
LEON发布了新的文献求助10
12秒前
12秒前
12秒前
嘀嘀嘀发布了新的文献求助10
13秒前
13秒前
完美世界的应助被zyy采纳,获得30
14秒前
DW的应助被Tang采纳,获得10
14秒前
弗洛伊德发布了新的文献求助10
14秒前
15秒前
XSJ关注了科研通微信公众号
15秒前
TJJJJJ完成签到,获得积分10
15秒前
流苏给流苏的求助进行了留言
16秒前
所所的应助被CITY111119采纳,获得10
16秒前
星辰大海的应助被礐嶨采纳,获得30
16秒前
老隋完成签到,获得积分10
16秒前
GWl完成签到,获得积分10
16秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Boundaries and Bodhisattvas 500
高分子基功能界面水蒸发材料与应用研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8181940
求助须知:如何正确求助?哪些是违规求助? 9571697
关于积分的说明 21819181
捐赠科研通 7778330
什么是DOI,文献DOI怎么找? 3433556
关于科研通互助平台的介绍 2557767
邀请新用户注册赠送积分活动 2479621